Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Monika Pajewska

Biographic Data

ID7859668
NAMEMonika Pajewska
GIVEN NAMESMonika
FAMILY NAMEPajewska
SIGNATUREPAJEWSKA M
AFFILIATIONSNarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy
ORCID0000-0002-7735-5219
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
AUTHOR COUNT5
EDITOR COUNT0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Influence of Selected Indicators of Healthcare System Functioning Evaluation on the Health Result

    Open Access•Olga Partyka, Monika Pajewska et al.•ARTICLE•International Journal of…•2022

    Life expectancy is positively correlated with access to general health insurance and public expenditure on healthcare. There is a need for all countries to provide their citizens with broad access to healthcare services

  • Civil Lawsuits as an Indicator of Adverse Outcomes in Healthcare

    Open Access•Marcin Mikos, Jolanta Budzowska et al.•ARTICLE•International Journal of…•2022

    The financial burden of adverse healthcare outcomes in Poland still remains unknown. The objective of the study was to estimate the cost of adverse healthcare outcomes in the Polish healthcare system. Cost calculation was performed on the basis of civil cases completed in Polish courts against doctors and healthcare entities. The research material consisted of 183 civil cases completed by a final judgment in 2011-2013. The case study was conducte…

  • Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union

    Open Access•Paweł Żelewski, Michał Wojna et al.•ARTICLE•International Journal of…•2022

    The 2019 worldwide sales of Orphan Drugs were estimated at $136 billion USD, which constituted 16% of the global pharmaceutical prescription market and is expected to grow by 12% in the next 5 years. A better understanding of Orphan Drug pricing may contribute to on-going discussions on Orphan Drug Act (ODA) corrections in US or modifications of price setting mechanisms in EU. The objective of the study was comparison and analysis of the prices o…

  • Normalization of the Mini-MAC (Mental Adjustment to Cancer) Questionnaire among Cancer Patients

    Open Access•Aleksandra Czerw, Urszula Religioni et al.•ARTICLE•International Journal of…•2021

    Cancer is associated with discomfort and many changes in patients' lives to which they must adapt. The main objective of the study was to assess the use of the mini-MAC questionnaire scale among persons diagnosed with malignant cancer and to develop standards allowing differentiation of patients with diagnosed cancer in terms of their style of adjustment to the disease. The mini-MAC questionnaire is a widely used tool in assessing coping strategi…

  • Pain Control

    Open Access•Aleksandra Czerw, Urszula Religioni et al.•ARTICLE•International Journal of…•2021

    The purpose of this article is to examine the applicability of the Beliefs about Pain Control Questionnaire (BPCQ) among cancer patients and develop norms that allow differentiation of patients with diagnosed cancer in terms of beliefs about pain control. Normalization aims to establish the value of test results in the study population. The study involved 1187 patients diagnosed with cancer in outpatient care Maria Sklodowska-Curie Cancer Center …

No prominent works on this page.

  • Normalization of the Mini-MAC (Mental Adjustment to Cancer) Questionnaire among Cancer Patients

    Open Access•Aleksandra Czerw, Urszula Religioni et al.•ARTICLE•International Journal of…•2021

    Cancer is associated with discomfort and many changes in patients' lives to which they must adapt. The main objective of the study was to assess the use of the mini-MAC questionnaire scale among persons diagnosed with malignant cancer and to develop standards allowing differentiation of patients with diagnosed cancer in terms of their style of adjustment to the disease. The mini-MAC questionnaire is a widely used tool in assessing coping strategi…

  • Pain Control

    Open Access•Aleksandra Czerw, Urszula Religioni et al.•ARTICLE•International Journal of…•2021

    The purpose of this article is to examine the applicability of the Beliefs about Pain Control Questionnaire (BPCQ) among cancer patients and develop norms that allow differentiation of patients with diagnosed cancer in terms of beliefs about pain control. Normalization aims to establish the value of test results in the study population. The study involved 1187 patients diagnosed with cancer in outpatient care Maria Sklodowska-Curie Cancer Center …

  • Influence of Selected Indicators of Healthcare System Functioning Evaluation on the Health Result

    Open Access•Olga Partyka, Monika Pajewska et al.•ARTICLE•International Journal of…•2022

    Life expectancy is positively correlated with access to general health insurance and public expenditure on healthcare. There is a need for all countries to provide their citizens with broad access to healthcare services

  • Civil Lawsuits as an Indicator of Adverse Outcomes in Healthcare

    Open Access•Marcin Mikos, Jolanta Budzowska et al.•ARTICLE•International Journal of…•2022

    The financial burden of adverse healthcare outcomes in Poland still remains unknown. The objective of the study was to estimate the cost of adverse healthcare outcomes in the Polish healthcare system. Cost calculation was performed on the basis of civil cases completed in Polish courts against doctors and healthcare entities. The research material consisted of 183 civil cases completed by a final judgment in 2011-2013. The case study was conducte…

  • Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union

    Open Access•Paweł Żelewski, Michał Wojna et al.•ARTICLE•International Journal of…•2022

    The 2019 worldwide sales of Orphan Drugs were estimated at $136 billion USD, which constituted 16% of the global pharmaceutical prescription market and is expected to grow by 12% in the next 5 years. A better understanding of Orphan Drug pricing may contribute to on-going discussions on Orphan Drug Act (ODA) corrections in US or modifications of price setting mechanisms in EU. The objective of the study was comparison and analysis of the prices o…

Medicine (5 works) · Business (3 works) · Population (3 works) · Cancer (2 works) · Cancer survivorship and care (2 works) · Childhood Cancer Survivors' Quality of Life (2 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Economic growth (2 works) · Economics (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae